144 related articles for article (PubMed ID: 18549685)
1. Effect of cetrorelix dose on premature LH surge during ovarian stimulation.
Lin YH; Seow KM; Chen HJ; Hsieh BC; Huang LW; Tzeng CR; Hwang JL
Reprod Biomed Online; 2008 Jun; 16(6):772-7. PubMed ID: 18549685
[TBL] [Abstract][Full Text] [Related]
2. The impact of LH serum concentration on the clinical outcome of IVF cycles in patients receiving two regimens of clomiphene citrate/gonadotrophin/0.25 mg cetrorelix.
Tavaniotou A; Albano C; Van Steirteghem A; Devroey P
Reprod Biomed Online; 2003 Jun; 6(4):421-6. PubMed ID: 12831586
[TBL] [Abstract][Full Text] [Related]
3. Suppression of the endogenous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist Cetrorelix during ovarian stimulation.
Diedrich K; Diedrich C; Santos E; Zoll C; al-Hasani S; Reissmann T; Krebs D; Klingmüller D
Hum Reprod; 1994 May; 9(5):788-91. PubMed ID: 7929723
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of cetrorelix for the prevention of premature luteinizing hormone surge during controlled ovarian stimulation using letrozole and gonadotropins: a randomized trial.
Lee TH; Lin YH; Seow KM; Hwang JL; Tzeng CR; Yang YS
Fertil Steril; 2008 Jul; 90(1):113-20. PubMed ID: 18054932
[TBL] [Abstract][Full Text] [Related]
5. Ovarian stimulation by clomiphene citrate and hMG in combination with cetrorelix acetate for ICSI cycles.
Hwang JL; Huang LW; Hsieh BC; Tsai YL; Huang SC; Chen CY; Hsieh ML; Chen PH; Lin YH
Hum Reprod; 2003 Jan; 18(1):45-9. PubMed ID: 12525439
[TBL] [Abstract][Full Text] [Related]
6. Comparison of different doses of gonadotropin-releasing hormone antagonist Cetrorelix during controlled ovarian hyperstimulation.
Albano C; Smitz J; Camus M; Riethmüller-Winzen H; Van Steirteghem A; Devroey P
Fertil Steril; 1997 May; 67(5):917-22. PubMed ID: 9130900
[TBL] [Abstract][Full Text] [Related]
7. Effect of a lower-dose cetrorelix acetate protocol on in-vitro fertilization outcome.
Tzeng CR; Chen HJ; Lin YH; Hsieh BC; Huang LW; Hwang JL
Int J Gynaecol Obstet; 2008 Mar; 100(3):271-4. PubMed ID: 18045601
[TBL] [Abstract][Full Text] [Related]
8. Single dose application of cetrorelix in combination with clomiphene for friendly IVF: results of a feasibility study.
Engel JB; Olivennes F; Fanchin R; Frydman N; Le Dû A; Blanchet V; Frydman R
Reprod Biomed Online; 2003 Jun; 6(4):444-7. PubMed ID: 12831591
[TBL] [Abstract][Full Text] [Related]
9. Comparison of outcome of clomiphene citrate/human menopausal gonadotropin/cetrorelix protocol and buserelin long protocol--a randomized study.
Lin YH; Hwang JL; Seow KM; Huang LW; Hsieh BC; Tzeng CR
Gynecol Endocrinol; 2006 Jun; 22(6):297-302. PubMed ID: 16785154
[TBL] [Abstract][Full Text] [Related]
10. A single injection of a gonadotropin-releasing hormone (GnRH) antagonist (Cetrorelix) postpones the luteinizing hormone (LH) surge: further evidence for the role of GnRH during the LH surge.
Leroy I; d'Acremont M; Brailly-Tabard S; Frydman R; de Mouzon J; Bouchard P
Fertil Steril; 1994 Sep; 62(3):461-7. PubMed ID: 8062939
[TBL] [Abstract][Full Text] [Related]
11. Dose-finding study of Leuplin depot for prevention of premature luteinizing hormone surge during controlled ovarian stimulation: a pilot study in intrauterine insemination treatment.
Chen HJ; Lin YH; Huang MZ; Seow KM; Huang LW; Hsieh BC; Tzeng CR; Hwang JL
Taiwan J Obstet Gynecol; 2016 Apr; 55(2):235-8. PubMed ID: 27125407
[TBL] [Abstract][Full Text] [Related]
12. Revival of the natural cycles in in-vitro fertilization with the use of a new gonadotrophin-releasing hormone antagonist (Cetrorelix): a pilot study with minimal stimulation.
Rongières-Bertrand C; Olivennes F; Righini C; Fanchin R; Taïeb J; Hamamah S; Bouchard P; Frydman R
Hum Reprod; 1999 Mar; 14(3):683-8. PubMed ID: 10221695
[TBL] [Abstract][Full Text] [Related]
13. Is a lower dose of cetrorelix acetate effective for prevention of LH surge during controlled ovarian hyperstimulation?
Chen HJ; Lin YH; Hsieh BC; Seow KM; Hwang JL; Tzeng CR
J Assist Reprod Genet; 2006 Jun; 23(6):289-92. PubMed ID: 16865530
[TBL] [Abstract][Full Text] [Related]
14. Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin).
Olivennes F; Belaisch-Allart J; Emperaire JC; Dechaud H; Alvarez S; Moreau L; Nicollet B; Zorn JR; Bouchard P; Frydman R
Fertil Steril; 2000 Feb; 73(2):314-20. PubMed ID: 10685535
[TBL] [Abstract][Full Text] [Related]
15. [Revisiting the clomifene-gonadotropin protocol in IVF with the use of a GnRH antagonist].
Emperaire JC; Parneix I; Perraguin-Jayot S
Gynecol Obstet Fertil; 2003 Nov; 31(11):927-31. PubMed ID: 14623556
[TBL] [Abstract][Full Text] [Related]
16. Gonadotrophin-releasing hormone antagonists for assisted conception.
Al-Inany H; Aboulghar M
Cochrane Database Syst Rev; 2001; (4):CD001750. PubMed ID: 11687120
[TBL] [Abstract][Full Text] [Related]
17. A spontaneous luteinizing hormone surge is beneficial in women with unexplained infertility undergoing controlled ovarian hyperstimulation without in vitro fertilization.
Costello MF; Hughes GJ; Garrett DK; Hanjani A; Steigrad SJ
Int J Fertil Womens Med; 1998; 43(1):28-33. PubMed ID: 9532467
[TBL] [Abstract][Full Text] [Related]
18. Preserved pituitary response under ovarian stimulation with HMG and GnRH antagonists (Cetrorelix) in women with tubal infertility.
Felberbaum RE; Reissmann T; Küpker W; Bauer O; al Hasani S; Diedrich C; Diedrich K
Eur J Obstet Gynecol Reprod Biol; 1995 Aug; 61(2):151-5. PubMed ID: 7556837
[TBL] [Abstract][Full Text] [Related]
19. Antagonist protocol versus clomiphene in unexplained infertility: A randomized controlled study.
Nada AM; ElSetohy KA; Banat MM; Shaheen AF
Taiwan J Obstet Gynecol; 2016 Jun; 55(3):326-30. PubMed ID: 27343309
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of a low gonadotrophin-releasing hormone antagonist dose in preventing premature luteinizing hormone rise during controlled ovarian stimulation.
Tiboni GM; Palumbo P; Leonzio E; Gabriele E; Verna I; Giampietro F
Gynecol Endocrinol; 2011 Nov; 27(11):885-9. PubMed ID: 21500992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
